Analysis and imaging: PET

Neutron Capture Therapy: Principles and Applications

Volumn 9783642313349, Issue , 2012, Pages 201-212

  Nariai, Tadashi ^a   Ishiwata, Kiichi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901836839     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-31334-9_11     Document Type: Chapter

References (39)

1. Aihara T, Hiratsuka J, Morita N, Uno M, Sakurai Y, Maruhashi A, Ono K, Harada T (2006) First clinical case of boron neutron capture therapy for head and neck malignancies using 18FBPA PET. Head Neck 28:850-855
2. Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K, Shimahara M (2007) Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Oncol Rep 18:861-866
3. Bauer M, Wagner CC, Langer O (2008) Microdosing studies in humans: the role of positron emission tomography. Drugs R&D 9:73-81
4. Chen JC, Chang SM, Hsu FY, Wang HE, Liu RS (2004) MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma. Appl Radiat Isot 61:887-891
5. Cherry S, Phelps M (1996) Imaging brain function with positron emission tomography. In: Toga A, Mazziotta J (eds) Brain mapping: the methods. Academic, San Diego, pp 191-221
6. Coleman RE (2002) Value of FDG-PET scanning in management of lung cancer. Lancet 359:1361-1362
7. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914-924
8. Groves AM, Win T, Haim SB, Ell PJ (2007) Non-[18F]FDG PET in clinical oncology. Lancet Oncol 8:822-830
9. Hara T, Kosaka N, Kishi H (1998) PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39:990-995
10. Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R, Ido T (1998) Fluorine-18-labeled fl uoroboronophenylalanine PET in patients with glioma. J Nucl Med 39:325-333
11. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R (1998) Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Clin Cancer Res 4:1825-1832
12. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R (1998) Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res 4:1833-1841
13. Ishiwata K, Ido T, Kawamura M, Kubota K, Ichihashi M, Mishima Y (1991) 4-Borono-2-[18F] fl uoro-D, L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. Int J Rad Appl Instrum B 18:745-751
14. Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y (1991) Synthesis and radiation dosimetry of 4-borono-2-[18F] fl uoro-D, L-phenylalanine: a target compound for PET and boron neutron capture therapy. Int J Rad Appl Instrum A 42:325-328
15. Ishiwata K, Ido T, Honda C, Kawamura M, Ichihashi M, Mishima Y (1992) 4-Borono-2-[18F] fl uoro-D, L-phenylalanine: a possible tracer for melanoma diagnosis with PET. Int J Rad Appl Instrum B 19:311-318
16. Ishiwata K, Shiono M, Kubota K, Yoshino K, Hatazawa J, Ido T, Honda C, Ichihashi M, Mishima Y (1992) A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F] fl uoro-L-phenylalanine. Melanoma Res 2:171-179
17. Ishiwata K, Tsukada H, Kubota K, Nariai T, Harada N, Kawamura K, Kimura Y, Oda K, Iwata R, Ishii K (2005) Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography. Nucl Med Biol 32:253-262
18. Ishiwata K, Kubota K, Nariai T, Iwata R (2008) Whole-body tumor imaging: [O-11C]methyl-L-tyrosine/positron emission tomography. In: Hayat M (ed) Cancer imaging: instrument and application, vol 2. Elsevier, Amsterdam, pp 175-179
19. Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, Reddy NK, Buonocore E, Hubner KF (1997) Evaluation of fl uorine-18-BPA-fructose for boron neutron capture treatment planning. J Nucl Med 38:1762-1767
20. Kabalka GW, Nichols TL, Smith GT, Miller LF, Khan MK, Busse PM (2003) The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J Neurooncol 62:187-195
21. Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M, Yura Y (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61:1069-1073
22. Kubota K (2001) From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 15:471-486
23. Kubota R, Yamada S, Ishiwata K, Tada M, Ido T, Kubota K (1993) Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo. Br J Cancer 67:701-705
24. Langen KJ, Muhlensiepen H, Holschbach M, Hautzel H, Jansen P, Coenen HH (2000) Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. J Nucl Med 41:1250-1255
25. Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, Sakurai Y, Masunaga S, Nagata K, Maruhashi A, Ono K (2005) Modi fi ed boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an ef fi cacy study based on fi ndings on neuroimages. J Neurosurg 103:1000-1009
26. Miyatake S, Tamura Y, Kawabata S, Iida K, Kuroiwa T, Ono K (2007) Boron neutron capture therapy for malignant tumors related to meningiomas. Neurosurgery 61:82-90; discussion 90-81
27. Miyatake SI, Kawabata S, Nonoguchi N, Yokoyama K, Kuroiwa T, Ono K (2009) Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas. Neuro Oncol 11(4):430-436
28. Nariai T, Senda M, Ishii K, Maehara T, Wakabayashi S, Toyama H, Ishiwata K, Hirakawa K (1997) Three-dimensional imaging of cortical structure, function and glioma for tumor resection. J Nucl Med 38:1563-1568
29. Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, Senda M, Ishii K, Hirakawa K, Ohno K (2005) Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498-507
30. Nariai T, Ishiwata K, Kimura Y, Inaji M, Momose T, Yamamoto T, Matsumura A, Ishii K, Ohno K (2009) PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. Appl Radiat Isot 67:S348-S350
31. Phelps ME, Mazziotta JC (1985) Positron emission tomography: human brain function and biochemistry. Science 228:799-809
32. Phelps ME, Hoffman EJ, Mullani NA, Ter-Pogossian MM (1975) Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med 16:210-224
33. Raichle ME (1983) Positron emission tomography. Annu Rev Neurosci 6:249-267
34. Sanchez del Pino MM, Peterson DR, Hawkins RA (1995) Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier. J Biol Chem 270:14913-14918
35. Suhara T, Takano A, Sudo Y, Ichimiya T, Inoue M, Yasuno F, Ikoma Y, Okubo Y (2003) High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fl uvoxamine using positron emission tomography. Arch Gen Psychiatry 60:386-391
36. Vahatalo JK, Eskola O, Bergman J, Forsback S, Lehikoinen P, Jaaskelainen J, Solin O (2002) Synthesis of 4-dihydroxyboryl-2-[F-18] fl uorophenylalanine with relatively high-speci fi c activity. J Label Compd Radiopharm 45:697-704
37. Wang HE, Liao AH, Deng WP, Chang PF, Chen JC, Chen FD, Liu RS, Lee JS, Hwang JJ (2004) Evaluation of 4-borono-2-18F-fl uoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model. J Nucl Med 45:302-308
38. Wittig A, Michel J, Moss RL, Stecher-Rasmussen F, Arlinghaus HF, Bendel P, Mauri PL, Altieri S, Hilger R, Salvadori PA, Menichetti L, Zamenhof R, Sauerwein WA (2008) Boron analysis and boron imaging in biological materials for boron neutron capture therapy (BNCT). Crit Rev Oncol Hematol 68:66-90
39. Yamamoto T, Nakai K, Kageji T, Kumada H, Endo K, Matsuda M, Shibata Y, Matsumura A (2009) Boron neutron capture therapy for newly diagnosed glioblastoma. Radiother Oncol 91:80-84